The report "Facial Implant Market by Product (Chin, Nasal, Malar, Jaw, Injectable), Material (Metal, Biologics, Polymers, Ceramics, Silicon), Shape (Anatomical, Oval, Round), Procedure (Rhinoplasty, Rhytidectomy, Chin Augmentation, Eyelid, Cheekbone, Forehead), End User (Hospitals, ASCs) - Global Forecasts to 2027", is projected to reach USD 4.2 billion by 2027 from USD 2.7 Billion in 2022, at a CAGR of 8% during the forecast period
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/facial-implant-market-206498478.html
Factors such as growing awareness about medical aesthetic procedures, technological advancements, and the increasing adoption of minimally invasive procedures are expected to support the growth of the facial implant market.
The chin and mandibular segment accounted for the largest share of the facial implant market in 2021.
Based on product, the facial implants market is segmented into chin & mandibular implants, nasal implants, malar & submalar implants, jaw implants, injectable implants, and others. In 2021, the chin & mandibular implants segment accounted for the largest share of the facial implants market. The key factors driving the growth of this market include innovation in implant materials, as well as growing adoption of minimally invasive chin augmentation & facelift procedures.
North America to command the largest share of the facial implants market in 2021
Based on region, the facial implants market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the facial implant market in 2021. The growth of the North American market is primarily driven by the increased number of aesthetic procedures and the high adoption rate of novel technologies in the region. Moreover, rising disposable income, awareness of new facial procedures, and the launch of new products fuel the adoption of facial implants in North America.
Prominent players in the facial implants market include Sientra Inc. (US), Johnson & Johnson (US), Zimmer Biomet (US), Stryker Corp. (US), Medartis AG (Switzerland), KLS Martin Group (US), Hanson Medical, Inc. (US), and AART Inc. (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com